Geffken Daniel E. is Chief Financial Officer of ProMIS Neurosciences Inc.
Person profile
Roles
ProMIS Neurosciences
Chief Financial Officer
Windtree Therapeutics
Director
Address
Concord, Massachusetts
Employees
Former names
Geffken Daniel E
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
CalciMedica, Inc.
20 May 24
4
CERO THERAPEUTICS HOLDINGS, INC.
16 Feb 24
4
ProMIS Neurosciences Inc.
30 Oct 23
4
WINDTREE THERAPEUTICS INC /DE/
29 Aug 23
4
CalciMedica, Inc.
3 May 23
3
CalciMedica, Inc.
3 May 23
3
ProMIS Neurosciences Inc.
7 Jul 22
4
WINDTREE THERAPEUTICS INC /DE/
9 Jun 22
4
Eloxx Pharmaceuticals, Inc.
1 Dec 21
4
PHOENIX BIOTECH ACQUISITION CORP.
12 Oct 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 May 24 | CALC CalciMedica | Warrant Common Stock | Grant | Acquire A | Yes | No | 5.45 | 10,000 | 54.50 k | 10,000 |
14 Feb 24 | CERO Phoenix Biotech Acquisition | Class A Common Stock | Other | Acquire J | No | No | 0 | 10,002 | 0.00 | 10,002 |
26 Oct 23 | PMN ProMIS Neurosciences | Option Common Shares | Grant | Acquire A | No | No | 1.87 | 2,500 | 4.68 k | 2,500 |
23 Aug 23 | WINT Windtree Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 2,033 | 0.00 | 2,175 |
23 Aug 23 | WINT Windtree Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.21 | 3,050 | 3.69 k | 3,050 |